Unknown

Dataset Information

0

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition.


ABSTRACT: Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive condition that is associated with the SMARCA4 mutation and has a dismal prognosis. It is generally diagnosed in young women. Here, we report a case of a young woman with SCCOHT harboring a rare molecular finding with a highly aggressive biological behavior. The patient had a somatic SMARCB1 mutation instead of an expected SMARCA4 alteration. Even though the patient was treated with high-dose chemotherapy followed by stem cell transplantation, she evolved with disease progression and died 11 months after her first symptoms appeared. We present a literature review of this rare disease and discuss the findings in the present patient in comparison to expected molecular alterations and options for SCCOHT treatment.

SUBMITTER: Simoes MFE 

PROVIDER: S-EPMC8870484 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with <i>SMARCB1</i> Mutation: A Literature Review of a Rare and Aggressive Condition.

Simões Maria Fernanda Evangelista MFE   da Costa Alexandre André Balieiro Anastácio AABA   Silva Tullio Novaes TN   Fernandes Lizieux L   Bovolim Graziele G   Torrezan Giovana Tardin GT   Carraro Dirce Maria DM   Baiocchi Glauco G   Menezes Ademir Narcizo Oliveira ANO   Santana Dos Santos Elizabeth E   De Brot Louise L  

Current oncology (Toronto, Ont.) 20220118 2


Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and aggressive condition that is associated with the <i>SMARCA4</i> mutation and has a dismal prognosis. It is generally diagnosed in young women. Here, we report a case of a young woman with SCCOHT harboring a rare molecular finding with a highly aggressive biological behavior. The patient had a somatic <i>SMARCB1</i> mutation instead of an expected <i>SMARCA4</i> alteration. Even though the patient was treated with high-d  ...[more]

Similar Datasets

| S-EPMC4811493 | biostudies-literature
| S-EPMC7847432 | biostudies-literature
| S-EPMC11497748 | biostudies-literature
| S-EPMC4195815 | biostudies-literature
| S-EPMC9323533 | biostudies-literature
| S-EPMC10692191 | biostudies-literature
| S-EPMC5563506 | biostudies-literature
| S-EPMC5722562 | biostudies-literature
| S-EPMC7381660 | biostudies-literature
| S-EPMC10692191 | biostudies-literature